Table 2.
Inhibitor | Lab. name | pKa_SA | K d_ obs (nM) | K d_ intr (nM) | ||||
---|---|---|---|---|---|---|---|---|
CA II | CA VI-mimic | CA VI | CA II | CA VI-mimic | CA VI | |||
1. | TFS | 6.02 | 20 | 33 | 14 | 8.0 | 15 | 1.2 |
2. | EZA | 7.82 | 1.3 (<5.0) | 17 (<54) | 33 (<54) | 0.073 | 1.1 | 0.40 |
3. | MZM | 6.86 | 100 | 330 | 830 | 27 | 97 | 44 |
4. | VD10-9 | 8.12 | 46 | 130 | 430 | 1.4 | 4.7 | 2.7 |
5. | VD10-12 | 8.61 | 18 | 100 | 1100 | 0.19 | 1.2 | 2.4 |
6. | VD10-13 | 8.14 | 11 | 130 | 200 | 0.32 | 4.2 | 1.2 |
7. | VD10-14 | 8.84 | 91 | 330 | 1000 | 0.57 | 2.4 | 1.3 |
8. | VD10-16 | 8.47 | 9.1 | 200 | 1200 | 0.13 | 3.3 | 3.7 |
9. | VD10-18 | 7.80 | 3.4 | 140 | 200 | 0.20 | 9.8 | 2.5 |
10. | VD10-35 | 7.28 | 17 | 130 | 67 | 2.5 | 22 | 2.1 |
11. | VD10-39b | 7.85 | 83 | 140 | 130 | 4.6 | 8.8 | 1.5 |
12. | VD10-45 | 7.69 | 5.8 | 140 | 140 | 0.43 | 12 | 2.2 |
13. | VD10-49 | 7.83 | 0.65 | 110 | 200 | 0.037 | 7.2 | 2.3 |
14. | VD10-50 | 8.02 | 9.6 (<43) | 330 (140) | 1000 (630) | 0.37 | 15 | 7.9 |
15. | VD11-9 | 8.05 | 1.7 | 100 | 400 | 0.061 | 4.1 | 3.0 |
16. | VD11-36 | 10.1 | 12 | 500 | 1100 | 0.0039 | 0.20 | 0.077 |
17. | VD11-67 | 8.67 | 5900 | 100 000 | 100 000 | 55 | 1000 | 190 |
18. | VD11-51 | 7.07 | 3.3 | 130 | 160 | 0.68 | 31 | 6.6 |
19. | VD11-56 | 7.97 | 20 | 330 | 500 | 0.86 | 16 | 4.4 |
20. | VD11-71 | 8.67 | 500 | 2500 | 3300 | 4.6 | 26 | 6.3 |
21. | VD12-04 | 8.67 | 1800 | 3300 | 20 000 | 17 | 35 | 38 |
22. | VD12-05 | 8.15 | 2.2 | 50 | 140 | 0.065 | 1.7 | 0.86 |
23. | VD12-10 | 10.2 | 25 (<36) | 500 (200) | 830 (3900) | 0.0070 | 0.16 | 0.048 |
24. | VD12-17 | 8.67 | 1300 | 5000 | 11 000 | 12 | 52 | 21 |
25. | VD11-4-2 | 8.01 | 56 | 100 | 67 | 2.2 | 4.5 | 0.54 |
26. | VD11-10 | 7.22 | 1.2 | 67 | 140 | 0.21 | 13 | 4.8 |
27. | VD11-16 | 7.87 | 35 | 1000 | 2000 | 1.9 | 59 | 22 |
28. | VD11-17 | 7.87 | 50 | 140 | 330 | 2.6 | 8.5 | 3.6 |
29. | VD11-28 | 7.87 | 6.7 | 200 | 110 | 0.35 | 12 | 1.2 |
30. | VD11-31 | 9.96 | 140 | 1000 | 5000 | 0.070 | 0.55 | 0.50 |
31. | VD11-39 | 7.87 | 33 | 2000 | 1000 | 1.8 | 120 | 11 |
32. | VD11-61 | 8.53 | 3.3 | 140 | 330 | 0.042 | 2.1 | 0.87 |
33. | E46 | 8.90 | 50 | 50 | 200 | 0.28 | 0.31 | 0.23 |
34. | E11-6 | 8.70 | 5.6 | 330 | 1100 | 0.048 | 3.3 | 2.0 |
35. | E11-11 | 9.40 | 1000 | 2000 | 13 000 | 1.8 | 4.0 | 4.5 |
36. | E11-12 | 8.90 | 8.5 | 500 | 5000 | 0.047 | 3.1 | 5.7 |
37. | E11-14 | 8.90 | 7.1 | 330 | 3300 | 0.039 | 2.1 | 3.8 |
38. | E11-15 | 9.40 | 560 | 1300 | 5000 | 0.98 | 2.5 | 1.8 |
39. | E11-18 | 8.90 | 28 (<54) | 500 (300) | 2500 (1600) | 0.15 | 3.1 | 2.8 |
40. | E11-37 | 9.60 | 3600 | 3300 | 6700 | 4.0 | 4.2 | 1.5 |
41. | E11-36 | 8.30 | 8.3 | 500 | 3300 | 0.16 | 12 | 14 |
42. | E11-52 | 8.70 | 2.9 | 330 | 1400 | 0.025 | 3.3 | 2.5 |
43. | E11-53 | 9.60 | 1700 | 3300 | 10 000 | 1.9 | 4.2 | 2.3 |
44. | E11-57 | 9.60 | 140 | 500 | 3300 | 0.16 | 0.63 | 0.75 |
45. | E11-60 | 8.70 | 250 | 500 | 3300 | 2.2 | 4.9 | 5.9 |
46. | E11-64 | 9.40 | 100 | 1100 | 17 000 | 0.16 | 2.2 | 5.5 |
The observed inhibitor affinities for CA VI-mimic were obtained experimentally by FTSA (pH 7.0, 37 °C), whereas the intrinsic parameters were calculated from the corresponding observed data using pKa of 7.0 for CA VI-mimic at 37 °C as explained in the methods part. The standard error of Kd measurements is ±2-fold. The pKa values of applied sulfonamide amino group (pKa_SA) and inhibitor affinities towards CA II and CA VI have been already reported58,86. Dissociation constants Kds of selected compounds were confirmed by SFA (pH 7.5). Experiments were performed at 23 °C and observed Kds were extrapolated to 37 °C using van’t Hoff equation when enthalpy of binding is −42 kJ/mol. The values at 37 °C are given in parentheses. The determined Kds at 23 °C are given in Table S2.